ArticleCancer immunology, immunotherapy : CII2020

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.

Robin Fröbom et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.